Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00621374 · ClinicalTrials.gov registry record · NA

Management of Pain in Persons With Multiple Sclerosis

A NA study of Pain and Multiple Sclerosis, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT00621374: Completed NA study of Pain and Multiple Sclerosis, sponsored by University of Washington.

NCT00621374 is a NA study of Pain and Multiple Sclerosis that has completed, run by University of Washington. The registered enrollment target is 22 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00621374, a NA study of Pain and Multiple Sclerosis, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Cognitive Behavioral Therapy (CBT) +Hypnosis (HYP)
  • BEHAVIORAL Self-Hypnosis Training (HYP)
  • BEHAVIORAL Education Control (CONT)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2008-02
Est. Completion 2009-06
Phase NA
University of Washington

1,048 total trials

What the finished NCT00621374 record still lists

NCT00621374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00621374 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00621374 about?

NCT00621374 is a clinical study titled "Management of Pain in Persons With Multiple Sclerosis". The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.

What is the current status of trial NCT00621374?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2008-02. Estimated completion is 2009-06.

What conditions does trial NCT00621374 study?

This clinical trial studies the following conditions: Pain, Multiple Sclerosis.

What interventions are being tested in trial NCT00621374?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Cognitive Behavioral Therapy (CBT) +Hypnosis (HYP) (BEHAVIORAL), Self-Hypnosis Training (HYP) (BEHAVIORAL), Education Control (CONT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00621374?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00621374 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00621374's enrollment target sits among peer trials

22 335th of 374 higher than 39 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00621374, the US trial registry maintained by the National Library of Medicine. NCT00621374 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.